Future Fields

Private Company

Using fruit flies to make recombinant proteins. Helping scientists change the world.

Future Fields' EntoEngine™ platform produces serum-free, bioactive growth factors and other recombinant proteins more sustainably than traditional expression systems.

Future Fields' EntoEngine™ deploys Drosophila melanogaster - or the common fruit fly. The company supercharge this tiny but mighty organism with synthetic biology and scale it with the efficiencies of insect farming. The end result? Active, sustainable, and cost-effective biomolecules.

Biomolecules produced by the EntoEngine™ are optimized for food, health, and life science research innovations.

Stay connected and informed.

Get the latest company news, scientific developments, product launches, and more direct to your inbox with our free weekly newsletter.

Thank you! You will hear from us soon!
Oops! Something went wrong while submitting the form.
Cell Based News
Showcasing the scientific breakthroughs, exciting companies and industry pioneers leading the cell based food and materials revolution.